Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
9619 | 1070 | 54.2 | 94% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | APOBEC3G | Author keyword | 207 | 84% | 10% | 112 |
2 | VIF | Author keyword | 190 | 78% | 12% | 124 |
3 | APOBEC3F | Author keyword | 77 | 96% | 2% | 24 |
4 | APOBEC3 | Author keyword | 62 | 73% | 4% | 48 |
5 | MOL RETROVIROL UNIT | Address | 27 | 76% | 2% | 19 |
6 | APOBEC | Author keyword | 25 | 63% | 2% | 25 |
7 | HIV 1 VIF | Author keyword | 20 | 100% | 1% | 9 |
8 | APOBEC3B | Author keyword | 18 | 89% | 1% | 8 |
9 | APOBEC3A | Author keyword | 17 | 100% | 1% | 8 |
10 | APOBEC3H | Author keyword | 14 | 100% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | APOBEC3G | 207 | 84% | 10% | 112 | Search APOBEC3G | Search APOBEC3G |
2 | VIF | 190 | 78% | 12% | 124 | Search VIF | Search VIF |
3 | APOBEC3F | 77 | 96% | 2% | 24 | Search APOBEC3F | Search APOBEC3F |
4 | APOBEC3 | 62 | 73% | 4% | 48 | Search APOBEC3 | Search APOBEC3 |
5 | APOBEC | 25 | 63% | 2% | 25 | Search APOBEC | Search APOBEC |
6 | HIV 1 VIF | 20 | 100% | 1% | 9 | Search HIV+1+VIF | Search HIV+1+VIF |
7 | APOBEC3B | 18 | 89% | 1% | 8 | Search APOBEC3B | Search APOBEC3B |
8 | APOBEC3A | 17 | 100% | 1% | 8 | Search APOBEC3A | Search APOBEC3A |
9 | APOBEC3H | 14 | 100% | 1% | 7 | Search APOBEC3H | Search APOBEC3H |
10 | DNA CYTOSINE DEAMINATION | 11 | 100% | 1% | 6 | Search DNA+CYTOSINE+DEAMINATION | Search DNA+CYTOSINE+DEAMINATION |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | ENZYME APOBEC3G | 322 | 82% | 17% | 186 |
2 | VIF PROTEIN | 262 | 70% | 20% | 215 |
3 | TYPE 1 VIF | 251 | 91% | 10% | 106 |
4 | HIV 1 VIF | 212 | 87% | 10% | 105 |
5 | ANTIRETROVIRAL FACTOR | 167 | 95% | 5% | 56 |
6 | EDITING ENZYME APOBEC3G | 156 | 90% | 6% | 69 |
7 | VIRION INFECTIVITY FACTOR | 137 | 81% | 8% | 82 |
8 | CYTIDINE DEAMINATION | 134 | 90% | 5% | 57 |
9 | CYTIDINE DEAMINASES | 125 | 82% | 7% | 73 |
10 | RESTRICTIVE CELLS | 103 | 97% | 3% | 30 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Multiple APOBEC3 Restriction Factors for HIV-1 and One Vif to Rule Them All | 2014 | 26 | 267 | 83% |
APOBEC proteins and intrinsic resistance to HIV-1 infection | 2009 | 118 | 132 | 89% |
The APOBEC3 cytidine deaminases: An innate defensive network opposing exogenous retroviruses and endogenous retroelements | 2008 | 209 | 160 | 80% |
APOBECs and virus restriction | 2015 | 2 | 226 | 76% |
HIV-I Vif, APOBEC, and intrinsic immunity | 2008 | 161 | 182 | 88% |
Interactions of host APOBEC3 restriction factors with HIV-1 in vivo: implications for therapeutics | 2010 | 70 | 160 | 91% |
APOBEC-mediated viral restriction: not simply editing? | 2007 | 156 | 100 | 81% |
Structure-Guided Analysis of the Human APOBEC3-HIV Restrictome | 2014 | 8 | 163 | 81% |
HIV-1 accessory proteins - Ensuring viral survival in a hostile environment | 2008 | 279 | 101 | 40% |
Suppression of APOBEC3-mediated restriction of HIV-1 by Vif | 2014 | 6 | 239 | 92% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL RETROVIROL UNIT | 27 | 76% | 1.8% | 19 |
2 | VIRAL BIOCHEM SECT | 11 | 46% | 1.7% | 18 |
3 | GENOME ENGNMASONIC CANC | 11 | 100% | 0.6% | 6 |
4 | GENOME ENGN | 7 | 21% | 2.9% | 31 |
5 | RETROVIROL SELF DEF | 7 | 67% | 0.6% | 6 |
6 | BECKMAN GENOME ENGN | 6 | 80% | 0.4% | 4 |
7 | VIROL AIDS | 6 | 33% | 1.3% | 14 |
8 | VIRAL MUTAT SECT | 5 | 35% | 1.1% | 12 |
9 | MOL CELLULAR DEV BIOL GENET | 5 | 63% | 0.5% | 5 |
10 | SECT VIRAL GENE REGULAT | 3 | 50% | 0.4% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000188984 | VPR//VPX//HIV 1 VPR |
2 | 0.0000172185 | VPU//BST 2//TETHERIN |
3 | 0.0000166708 | TRIM5 ALPHA//TRIMCYP//TRIM5 |
4 | 0.0000115939 | XMRV//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS//XENOTROPIC MURINE LEUKEMIA VIRUS RELATED VIRUS XMRV |
5 | 0.0000092327 | SOMATIC HYPERMUTATION//CLASS SWITCH RECOMBINATION//ACTIVATION INDUCED CYTIDINE DEAMINASE |
6 | 0.0000067102 | FOAMY VIRUS//SPUMARETROVIRUS//ABT RETROVIRALE GENEXP S |
7 | 0.0000065651 | NEF//HIV 1 NEF//HIV NEF |
8 | 0.0000060053 | RNA DIMERIZATION//NCP7//HIV 1 NUCLEOCAPSID PROTEIN |
9 | 0.0000059991 | VIRUS CELL INTERACT SECT//GAG//M PMV |
10 | 0.0000058272 | CYTIDINE DEAMINASE//ANTIBIOTIC FUNGICIDE//BLASTICIDIN S DEAMINASE |